Lucid Diagnostics earnings were -$65.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LUCD earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$14.7M, down 37.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LUCD reported annual earnings of -$70.6M, with 33.1% growth.
What were Lucid Diagnostics's earnings last quarter?
On LUCD's earnings call on Aug 13, 2026, Lucid Diagnostics (NASDAQ: LUCD) reported Q2 2026 earnings per share (EPS) of -$0.08, up 0% year over year. Total LUCD earnings for the quarter were -$14.72 million. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.08.
As of the last Lucid Diagnostics earnings report, Lucid Diagnostics is currently losing money. Lucid Diagnostics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$52.26 million, a 5.43% decrease year over year.
What was LUCD's earnings growth in the past year?
As of Lucid Diagnostics's earnings date in Aug 13, 2026, Lucid Diagnostics's earnings has grown year over year. LUCD earnings in the past year totalled -$65.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.